Home » ETF » SPBO

SPBO - SPDR Portfolio Corporate Bond ETF

Stock Price: $34.73 USD 0.14 (0.40%)
Updated Apr 13, 2021 4:00 PM EDT - Market closed
Assets $328.20M
NAV $34.73
Expense Ratio 0.06%
PE Ratio n/a
Beta (5Y) 0.18
Dividend (ttm) $0.97
Dividend Yield 2.81%
Ex-Dividend Date Apr 1, 2021
1-Year Return -
Trading Day April 13
Last Price $34.73
Previous Close $34.59
Change ($) 0.14
Change (%) 0.40%
Day's Open 34.60
Day's Range 34.58 - 34.73
Day's Volume 33,772
52-Week Range 32.46 - 36.02

Fund Description

The investment seeks investment results that, before fees and expenses, correspond generally to the price and yield performance of an index that tracks the Bloomberg Barclays U.S. Corporate Bond Index. The fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index and in securities that the Adviser determines have economic characteristics that are substantially identical to the economic characteristics of the securities that comprise the index. The index is designed to measure the performance of the investment grade corporate bond market.

Asset Class
Fixed Income
Inception Date
Apr 6, 2011
Exchange
NYSEARCA
Ticker Symbol
SPBO
Index Tracked
Bloomberg Barclays U.S. Corporate Bond Index

Top 10 Holdings

2.74% of assets
NameSymbolWeight
Citigroup Inc. 3.2%n/a0.37%
Wells Fargo & Company 4.65%n/a0.30%
State Street Institutional Liq State St Inst Liq Res Prem3227.T0.30%
Morgan Stanley 6.38%n/a0.27%
AT&T Inc 3.8%n/a0.26%
Verizon Communications Inc. 4.12%n/a0.25%
HSBC Holdings plc 6.5%n/a0.25%
Intel Corporation 2.45%n/a0.25%
Barclays PLC 5.2%n/a0.24%
Comcast Corporation 4.15%CMCSA 4.15 10/15/280.24%
View All Holdings

Dividends

Ex-DividendAmountPay Date
Apr 1, 2021$0.07Apr 8, 2021
Mar 1, 2021$0.073Mar 5, 2021
Feb 1, 2021$0.072Feb 5, 2021
Dec 18, 2020$0.109Dec 24, 2020
Nov 2, 2020$0.076Nov 6, 2020
Oct 1, 2020$0.078Oct 7, 2020
Full Dividend History

News

Amid very-low interest rate environment, investors may be interested in securities that have the potential to offer capital appreciation as well as benchmark-beating yields.

Other tickers mentioned: CDC, IVOL, QDEF, VRP
9 months ago - Zacks Investment Research